Pidilite Industries Ltd (NSE: PIDILITIND) reported solid Q3 FY26 consolidated results: revenue from operations ₹3,710 crore, net profit ₹618 crore. Volume-led expansion in Fevicol, Dr Fixit segments amid stable margins; outlook optimistic with rural recovery, innovation driving 10%+ volume growth trajectory.
Performance Snapshot
Pidilite Industries, the adhesives giant behind Fevicol and Dr Fixit, announced Q3 FY26 (Dec quarter) earnings on February 3, 2026. Consolidated revenue from operations reached ₹37.1 billion (₹3,710 crore), reflecting robust demand in consumer & bazaar (80% revenue) and B2B segments.
Net profit stood at ₹6.18 billion (₹618 crore), supported by EBITDA margins ~24%, lower input costs, and 9-10% underlying volume growth (UVG) across urban/rural markets.
Strategic Insights
Building on Q2's ₹3,554 Cr revenue, H1 FY26 shows sustained momentum. Management highlights government spending boost for construction chemicals; R&D investments yield 93% commercialization rate.
Key Highlights
-
Revenue Growth: Ops revenue ₹37.1 bln (₹3,710 Cr); C&B UVG 7-8%, B2B 20%+.
-
Profitability: Net profit ₹6.18 bln (₹618 Cr); EBITDA ~₹890 Cr, margins steady 24%.
-
Volume Driver: 10% UVG; rural outpaces urban; new launches in waterproofing, sealants.
-
Outlook: Cautiously optimistic; festive tailwinds, infra push for FY26 double-digit growth.
Sources: Economic Times, Moneycontrol, MarketsMojo, Business Standard.